Product Information
MIRTAZAPINE 30 MG ODT is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4229 per EA under NDC 65862002206. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 8, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862002206
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077376FDA Approved
12/8/2005
TE Code
AB
On Market Since
12/8/2005
Price Statistics
The NADAC for MIRTAZAPINE 30 MG ODT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4229 per EA |
|---|---|
| All-time high | $0.9658 (Apr 13, 2016) |
| All-time low | $0.2242 (Jul 17, 2024) |
| 52-week high | $0.5089 |
| 52-week low | $0.4022 |
| Median price | $0.6693 |
| Average price | $0.6517 |
| Largest weekly change | +69.0% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 30 MG ODT, manufactured by Aurobindo Pharma Limited, is $0.4229 per EA (NDC 65862002206), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 30 MG ODT changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 30 MG ODT has declined 50.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 30 MG ODT?
Since Nov 28, 2013, the NADAC for MIRTAZAPINE 30 MG ODT has ranged from a low of $0.2242 (Jul 17, 2024) to a high of $0.9658 (Apr 13, 2016), with a median of $0.6693 per EA.
Are there cheaper alternatives to MIRTAZAPINE 30 MG ODT?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRTAZAPINE 30 MG TABLET, is $0.0723 per EA — about 83% below MIRTAZAPINE 30 MG ODT.
Who manufactures MIRTAZAPINE 30 MG ODT?
MIRTAZAPINE 30 MG ODT (NDC 65862002206) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.